WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008095504) A POLYCLONAL ANTIBODY PRODUCT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/095504    International Application No.:    PCT/DK2008/050027
Publication Date: 14.08.2008 International Filing Date: 07.02.2008
IPC:
C07K 16/08 (2006.01), C07K 16/18 (2006.01), A61K 39/395 (2006.01)
Applicants: SYMPHOGEN A/S [DK/DK]; Elektrovej building 375, DK-2800 Kgs. Lyngby (DK) (For All Designated States Except US).
HAURUM, John [DK/DK]; (DK) (For US Only)
Inventors: HAURUM, John; (DK)
Priority Data:
PA 2007 00222 09.02.2007 DK
60/900,325 09.02.2007 US
Title (EN) A POLYCLONAL ANTIBODY PRODUCT
(FR) ANTICORPS POLYCLONAUX
Abstract: front page image
(EN)The present invention relates to a composition comprising two or more sets of target-specific recombinant polyclonal antibodies, each set being capable of binding to a distinct target, wherein said distinct targets are related to diseases, which may be treated or prevented by the useof antibodies, and wherein said composition is essentially free from immunoglobulin molecules that do not bind to one of said distinct targets.Further the application describes pharmaceutical and diagnostic compositions comprising said composition and use in prevention, treatment and/oramelioration of one or more diseases.
(FR)La présente invention concerne une composition comprenant au moins deux ensembles d'anticorps polyclonaux recombinés spécifiques d'une cible, chaque ensemble pouvant se lier à une cible distincte. Lesdites cibles distinctes sont liées à des maladies, lesquelles peuvent être traitées ou empêchées par l'utilisation d'anticorps. Ladite composition est essentiellement exempte de molécules d'immunoglobuline qui ne se lient pas à l'une desdites cibles distinctes. L'invention concerne en outre des compositions pharmaceutiques et diagnostiques comprenant ladite composition et leur utilisation dans la prévention, le traitement et/ou l'amélioration d'une ou plusieurs maladies.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)